OSI stock falters on Tarceva sales concerns Shares of OSI Pharmaceuticals Inc. fell sharply Friday on concerns about the newly approved drug #39;s ability to meet sales targets. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 